80 related articles for article (PubMed ID: 20458505)
1. Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan.
Ueda D; Hori T; Nguyen JH; Uemoto S
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):885-91. PubMed ID: 20458505
[TBL] [Abstract][Full Text] [Related]
2. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
[No Abstract] [Full Text] [Related]
3. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
4. Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.
Kerkar N; Morotti RA; Iyer K; Arnon R; Miloh T; Sturdevant M; Suchy F; Florman S; Emre S
Clin Transplant; 2011; 25(6):E584-91. PubMed ID: 21919961
[TBL] [Abstract][Full Text] [Related]
5. Muromonab-CD3 for the successful treatment of early chronic rejection after pediatric liver transplantation: report of a case.
Hori T; Nguyen JH; Uemoto S
Surg Today; 2011 Apr; 41(4):585-90. PubMed ID: 21431500
[TBL] [Abstract][Full Text] [Related]
6. Steroid-resistant acute rejections after liver transplant.
Aydogan C; Sevmis S; Aktas S; Karakayali H; Demirhan B; Haberal M
Exp Clin Transplant; 2010 Jun; 8(2):172-7. PubMed ID: 20565375
[TBL] [Abstract][Full Text] [Related]
7. [OKT3 for recipients with steroid-resistant acute rejection after liver transplantation].
Wu LW; He XS; Zhu XF; Wang DP; Ju WQ; Tai Q; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):857-8. PubMed ID: 18073076
[No Abstract] [Full Text] [Related]
8. OKT3 treatment in refractory pediatric heart transplant rejection.
Wilmot I; Kanter KR; Vincent RN; Berg AM; Mahle WT
J Heart Lung Transplant; 2005 Nov; 24(11):1793-7. PubMed ID: 16297784
[TBL] [Abstract][Full Text] [Related]
9. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
Emre S; Gondolesi G; Polat K; Ben-Haim M; Artis T; Fishbein TM; Sheiner PA; Kim-Schluger L; Schwartz ME; Miller CM
Liver Transpl; 2001 Mar; 7(3):220-5. PubMed ID: 11244163
[TBL] [Abstract][Full Text] [Related]
10. Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience.
Hirata Y; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Katano T; Otomo S; Ushijima K; Mizuta K
Transplant Proc; 2018; 50(1):60-65. PubMed ID: 29407332
[TBL] [Abstract][Full Text] [Related]
11. Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients.
Sellers M; Singer A; Maller E; Olthoff K; Jacobowski D; Shaked A
Transplant Proc; 1997; 29(1-2):428-9. PubMed ID: 9123065
[No Abstract] [Full Text] [Related]
12. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
13. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
[No Abstract] [Full Text] [Related]
14. Basiliximab treatment for steroid-resistant rejection in pediatric patients following liver transplantation for acute liver failure.
Shigeta T; Sakamoto S; Uchida H; Sasaki K; Hamano I; Kanazawa H; Fukuda A; Kawai T; Onodera M; Nakazawa A; Kasahara M
Pediatr Transplant; 2014 Dec; 18(8):860-7. PubMed ID: 25311536
[TBL] [Abstract][Full Text] [Related]
15. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L
J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182
[TBL] [Abstract][Full Text] [Related]
17. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
18. Liver transplantation from cadaveric and living donors.
Lo CM; Lo RJ; Lai CL; Fan ST; Wong J
Transplant Proc; 1996 Jun; 28(3):1659-60. PubMed ID: 8658826
[No Abstract] [Full Text] [Related]
19. Refractory acute rejection in a living related liver transplantation.
Noritomi T; Sugawara Y; Kaneko J; Matsui Y; Makuuchi M
Hepatogastroenterology; 2003; 50(54):2192-3. PubMed ID: 14696495
[TBL] [Abstract][Full Text] [Related]
20. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
